Structure |
Chemical Name |
CAS |
MF |
 |
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
 |
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
 |
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
929540-41-0 |
C36H41CaFN2O5 |
 |
(S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid calcium(II) |
1659317-57-3 |
C33H35CaFN2O4 |
![2-[4-(2,3-Epoxypropoxy)phenyl]acetamid](/CAS/GIF/29122-69-8.gif) |
2-[4-(2,3-Epoxypropoxy)phenyl]acetamid |
29122-69-8 |
C11H13NO3 |
![1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)-](/CAS/20211123/GIF/862260-38-6.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)- |
862260-38-6 |
C36H40FN2NaO5 |
 |
Aprepitant iMpurity |
96730-04-0 |
C13H22NO4P |
 |
Aprepitant Impurity 17 |
1333998-27-8 |
C20H19ClF7NO2 |
![2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione](/CAS/20180528/GIF/1809464-27-4.gif) |
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
 |
Aprepitant impurity C |
|
|
 |
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
![2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE](/CAS/GIF/61698-76-8.gif) |
2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE |
61698-76-8 |
C11H15NO4 |
![1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)-](/CAS/20210305/GIF/2588261-38-3.gif) |
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)- |
2588261-38-3 |
C37H43FN2O5 |
 |
4-Acetoxyisophthalic Acid |
5985-26-2 |
C10H8O6 |
 |
(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one |
327623-36-9 |
C21H19F6NO3 |
 |
Atorvastatin lactone |
125995-03-1 |
C33H33FN2O4 |
 |
Aprepitant |
170902-80-4 |
C20H18F7NO2 |
 |
Aprepitant Impurity 33 |
502537-39-5 |
C20H20F7NO3 |
 |
Cytarabine Impurity 10 |
32830-01-6 |
C9H11N3O4 |
 |
Aprepitant Impurity 44 |
172676-88-9 |
C23H21F7N4O3 |
 |
Aprepitant iMpurity 37 |
|
|
 |
(2Z)-2,3-Dehydroxy Atorvastatin (>90% Z) |
1191901-60-6 |
C33H33FN2O4 |
![[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine](/CAS/GIF/170729-79-0.gif) |
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine |
170729-79-0 |
C20H18F7NO2 |
 |
Atorvastatin Lactam Impurity |
906552-18-9 |
C33H35FN2O6 |
 |
2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid
(Diketopiperazine) |
|
C29H42N8O18S4 |
![(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20210111/GIF/65576-39-8.gif) |
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
 |
(1R,2S,3R)-Aprepitant |
1185502-97-9 |
C23H21F7N4O3 |
 |
Aprepitant Impurity 22 |
934540-48-4 |
C20H16F7NO2 |
 |
Aprepitant Impurity 9 |
219821-37-1 |
C24H25F7N4O4 |
 |
Aprepitant Impurity 28 |
|
|
 |
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
 |
Aprepitant Impurity 53 |
|
|
 |
TRIBENZYLPHOSPHITE |
15205-57-9 |
C21H21O3P |
 |
Cytarabine Impurity 12 |
14057-18-2 |
C15H18N2O9 |
 |
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
 |
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
 |
Aprepitant Impurity 3 |
|
|
 |
Aprepitant Impurity 12 |
172673-23-3 |
C23H21F7N4O4 |
 |
Aprepitant Impurity 18 |
|
|
 |
Aprepitant Impurity 14 |
|
|
![2-[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]ACETAMIDE](/CAS/GIF/115538-83-5.gif) |
2-[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]ACETAMIDE |
115538-83-5 |
C11H14ClNO3 |
 |
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
![(4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester](/CAS/GIF/472967-95-6.gif) |
(4S,6S)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester |
472967-95-6 |
C40H47FN2O5 |
 |
Nsc529487 |
3310-47-2 |
C9H13N3O6 |
![(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride](/CAS/20150408/GIF/1333998-21-2.gif) |
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
 |
Atorvastatin Lactam Lactone |
1795791-15-9 |
C33H31FN2O5 |
 |
Aprepitant EP Impurity C |
2208275-99-2 |
C29H25F7N4O3 |
 |
Atorvastatin 2-Fluoro t-Butyl Ester |
1099474-28-8 |
C40H47FN2O5 |
 |
r-Cytidine |
13913-16-1 |
C9H13N3O5 |
 |
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
 |
Aprepitant Impurity 34 |
|
|
 |
Cytarabine Impurity 13 |
82855-62-7 |
C17H19N5O8 |
 |
Aprepitant iMpurity 38 |
|
|
 |
Aprepitant iMpurity 41 |
|
|
 |
Atorvastatin Oxirane Impurity |
1246818-88-1 |
C26H24FNO3 |
![3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt](/CAS/GIF/887196-25-0.gif) |
3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt |
887196-25-0 |
C33H34CaFN2O5+ |
 |
Atorvastatin Dehydro Lactone |
442851-50-5 |
C33H31FN2O3 |
 |
Avibactam Impurity 15 |
1416134-60-5 |
C15H20N2O3 |
 |
Difluoro Atorvastatin Acetonide tert-Butyl Ester |
693793-87-2 |
C40H46F2N2O5 |
 |
3-Oxo Atorvastatin tert-Butyl Ester |
134394-98-2 |
C37H41FN2O5 |
 |
tert-butyl 2-((4R,6S)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate |
|
C14H27NO4 |
 |
Axitinib Impurity 13 |
|
|
 |
Axitinib Impurity 18 |
|
|
 |
Avibactam Impurity |
2064219-26-5 |
C7H12N3NaO6S |
 |
Atorvastatin Impurity E Intermediate |
|
|
 |
Avibactam sodium Impurity CIS |
|
|
 |
(3R,5R)-7-(1-((3R,5R)-6-carboxy-3,5-dihydroxyhexyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamido)-3,5-dihydroxyheptanoic acid |
|
|
 |
Axitinib Impurity D |
1443118-72-6 |
C29H25N5OS |
 |
Atorvastatin Impurity 30 |
666714-64-3 |
C26H23FN2O |
 |
Avibactam Impurity R |
|
|
 |
Avibactam Impurity X |
|
|
 |
Avibactam Impurity 38 |
2241730-86-7 |
C20H29BrN2O5 |
 |
Atorvastatin Impurity 34 |
|
C66H68CaF2N4O10 |
 |
Axitinib Impurity 6 |
|
|
 |
ethyl 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan- 4-yl)acetate |
616201-27-5 |
C38H43FN2O5 |
 |
((((3R,6S)-6-carbamoylpiperidin-3-yl)(ethoxycarbonyl)amino)oxy)sulfonic acid |
|
|
![1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)-](/CAS/20210305/GIF/1046533-62-3.gif) |
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
 |
2,2'-(4,4'-(3,3'-(isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl))bis(oxy)bis(4,1-phenylene))diacetaMide |
87619-83-8 |
C25H35N3O6 |
 |
Aprepitant iMpurity A |
|
|
 |
Atorvastatin LactaM Phenanthrene CalciuM Salt |
1046378-58-8 |
C33H35CaFN2O6 |
![1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione](/CAS/20180601/GIF/69321-95-5.gif) |
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione |
69321-95-5 |
C9H12N2O7 |
 |
Aprepitant Impurity 23 |
|
|
 |
(3R,5R)-tert-butyl 7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
2588261-40-7 |
C37H42F2N2O5 |
 |
Aprepitant |
1242175-36-5 |
C20H18F7NO2 |
 |
Cytarabine Impurity 10 |
84902-98-7 |
C4H6N2O3 |
 |
3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(3-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
![2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE](/CAS/GIF/29277-73-4.gif) |
2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE |
29277-73-4 |
C14H20N2O2 |
![4-METHYL-3-[[1-OXO-2-(PROPYLAMINO)PROPYL]AMINO]-2-THIOPHENECARBOXYLIC ACID](/CAS/GIF/114176-52-2.gif) |
4-METHYL-3-[[1-OXO-2-(PROPYLAMINO)PROPYL]AMINO]-2-THIOPHENECARBOXYLIC ACID |
114176-52-2 |
C12H18N2O3S |
 |
10-trans-Atorvastatin Acetonide tert-Butyl Ester |
1105067-90-0 |
C40H47FN2O5 |
 |
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
 |
4,4'-(2-HYDROXY-1,3-PROPANDIYLDIOXY)BIS(2-PHENYLACETAMIDE) |
141650-31-9 |
C19H22N2O5 |
 |
Articaine IMpurity F (Articaine Acid PropionaMide HCl) |
|
|
 |
Aprepitant Impurity 6 |
170902-81-5 |
C23H21F7N4O3 |
 |
(3S,5S)-Atorvastatin (sodium salt) |
1428118-38-0 |
C33H36FN2NaO5 |
 |
Aprepitant Impurity 19 |
1333995-14-4 |
|
 |
Aprepitant Impurity 15 |
|
|
 |
Aprepitant iMpurity 45 |
|
|
![3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-](/CAS/20211123/GIF/1193817-52-5.gif) |
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
 |
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
![cis-5-Chlor-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol](/CAS/20180808/GIF/65621-78-5.gif) |
cis-5-Chlor-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol |
65621-78-5 |
C17H16ClNO |